Cargando…
COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro
BACKGROUND: An increasing number of reports is challenging the notion that the antitumor potential of the selective COX-2 inhibitor celecoxib (Celebrex(®)) is mediated primarily via the inhibition of COX-2. We have investigated this issue by applying two different analogs of celecoxib that different...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2396175/ https://www.ncbi.nlm.nih.gov/pubmed/18485224 http://dx.doi.org/10.1186/1476-4598-7-38 |